Page last updated: 2024-11-03

propofol and Myasthenic Syndromes, Congenital

propofol has been researched along with Myasthenic Syndromes, Congenital in 1 studies

Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.

Myasthenic Syndromes, Congenital: A heterogeneous group of disorders characterized by a congenital defect in neuromuscular transmission at the NEUROMUSCULAR JUNCTION. This includes presynaptic, synaptic, and postsynaptic disorders (that are not of autoimmune origin). The majority of these diseases are caused by mutations of various subunits of the nicotinic acetylcholine receptor (RECEPTORS, NICOTINIC) on the postsynaptic surface of the junction. (From Arch Neurol 1999 Feb;56(2):163-7)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Emura, M1
Ishii, H1
Baba, H1

Other Studies

1 other study available for propofol and Myasthenic Syndromes, Congenital

ArticleYear
[Anesthetic management of scoliosis surgery for a patient with congenital myasthenic syndrome].
    Masui. The Japanese journal of anesthesiology, 2014, Volume: 63, Issue:8

    Topics: Adolescent; Air; Anesthesia, General; Humans; Intestines; Lung Compliance; Male; Myasthenic Syndrome

2014